Gabor Istvan Liposits

Medicin og biovidenskab

1. Geriatrics 100%
2. Colorectal Neoplasms 75%
3. trifluridine tipiracil 66%
4. Bevacizumab 55%
5. Neoplasms 41%
6. Radiotherapy 39%
7. Capecitabine 35%
8. Geriatric Assessment 34%
9. Oxaliplatin 34%
10. Survival 30%
11. Breast Neoplasms 29%
12. Progression-Free Survival 29%
13. Therapeutics 28%
14. Drug Therapy 26%
15. Combination Drug Therapy 26%
16. Ovarian Neoplasms 25%
17. Poly(ADP-ribose) Polymerase Inhibitors 24%
18. Quality of Life 24%
19. Frailty 19%
20. human ERBB2 protein 18%
21. Pancreatic Neoplasms 17%
22. Clinical Trials 16%
23. Oncologists 16%
24. Patient Reported Outcome Measures 16%
25. Geriatric Nursing 15%
26. 130-nm albumin-bound paclitaxel 14%
27. Cyclin-Dependent Kinase 6 14%
28. Organ Motion 14%
29. Population 13%
30. Oncology Nursing 13%
31. Cyclin-Dependent Kinase 4 13%
32. Neutropenia 12%
33. Public Opinion 12%
34. Patient Positioning 12%
35. Coronavirus 11%
36. Central Nervous System Neoplasms 11%
37. Randomized Controlled Trials 11%
38. Phase III Clinical Trials 11%
39. Medical Oncology 11%
40. Cardiotoxicity 10%
41. Neutrophils 10%
42. gemcitabine 10%
43. Neoplasm Staging 10%
44. Pandemics 9%
45. Decision Making 9%
46. Photons 9%
47. Gene Expression Profiling 9%
48. Biomarkers 9%
49. Recurrence 9%
50. Systematic Reviews 9%